Peter Greenleaf

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Peter S. Greenleaf
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Greenleaf:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Chief Executive Officer, Director Common Stock 1,845,037 $29,428,340 $15.95 02 Jan 2026 Direct
Aurinia Pharmaceuticals Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 443,973 28 Feb 2025 Direct
Channel Therapeutics Corp Director Stock Option 77,640 02 Jul 2025 Direct
Channel Therapeutics Corp Director Restricted Stock Units 25,478 02 Jul 2025 Direct
ANTARES PHARMA, INC. Director Common Stock 0 $5.60 24 May 2022 Direct
ANTARES PHARMA, INC. Director Stock Option (right to buy) 0 24 May 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 22 Mar 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 22 Mar 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $2.93 22 Mar 2022 Direct

Insider Reports Filed by Peter Greenleaf

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUPH Aurinia Pharmaceuticals Inc. 02 Jan 2026 2 -$1,805,046 4 Chief Executive Officer, Director 05 Jan 2026, 16:10
PTHS Pelthos Therapeutics Inc. 02 Jul 2025 2 $0 4 Director 07 Jul 2025, 21:46
PTHS Pelthos Therapeutics Inc. 01 Jul 2025 0 $0 3 Director 07 Jul 2025, 21:40
AUPH Aurinia Pharmaceuticals Inc. 28 Feb 2025 5 -$2,871,124 4 Chief Executive Officer, Director 04 Mar 2025, 21:02
AUPH Aurinia Pharmaceuticals Inc. 06 Mar 2024 1 -$711,094 4 Chief Executive Officer, Director 07 Mar 2024, 16:46
AUPH Aurinia Pharmaceuticals Inc. 20 Feb 2024 1 $0 4 Chief Executive Officer, Director 22 Feb 2024, 16:25
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 1 -$290,153 4/A Chief Executive Officer, Director 22 Feb 2024, 16:15
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 2 -$292,785 4 Chief Executive Officer, Director 06 Mar 2023, 15:27
ATRS ANTARES PHARMA, INC. 24 May 2022 6 -$446,012 4 Director 26 May 2022, 17:22
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC 22 Mar 2022 4 $0 4 Director 22 Mar 2022, 17:12
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2022 4 -$108,907 4 Chief Executive Officer, Director 04 Mar 2022, 15:11
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC 27 Jan 2022 4 +$418,510 4 Director 31 Jan 2022, 17:02
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC 06 Aug 2021 2 $0 4 Director 10 Aug 2021, 18:17
ATRS ANTARES PHARMA, INC. 10 Jun 2021 2 +$112,498 4 Director 14 Jun 2021, 18:22
AUPH Aurinia Pharmaceuticals Inc. 11 May 2021 2 +$54,891 4 Chief Executive Officer, Director 12 May 2021, 16:32